Search research articles
Contact Us
Filters
Showing results (961-970 of 1,607) with videos related to
Page
of 161
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population
Danielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Journal of Animal Science
|
January 27, 2016
Relationship of glucocorticoids and hematological measures with feed intake, growth, and efficiency of finishing beef cattle
A P Foote, K E Hales, R G Tait, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 19, 2017
Experience with telemedicine in a multi-disciplinary ALS clinic
Marc Van De Rijn, Sabrina Paganoni, Mark Levine-Weinberg, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 9, 2022
Correction to: Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data
Joel Mintz, Matthew S Duprey, Andrew R Zullo, et al.
Diabetes & Vascular Disease Research
|
July 17, 2014
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?
Martin Sénéchal, Colby R Ayers, Lidia S Szczepaniak, et al.
Journal of Immunological Methods
|
October 16, 2007
High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxins
Cindi R Corbett, Mohammad D Elias, Lance L Simpson, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer
C J Gilbert, W P Petros, J Vredenburgh, et al.
Diabetes, Obesity & Metabolism
|
April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)
Z Skrivanek, B L Gaydos, J Y Chien, et al.
Drug Discovery Today
|
September 11, 2014
Neuroprotective agents target molecular mechanisms of disease in ALS
Yongjin Zhu, Anastasios Fotinos, Lilly L J Mao, et al.
Journal of the American Heart Association
|
November 17, 2021
Cigarette Smoking and Competing Risks for Fatal and Nonfatal Cardiovascular Disease Subtypes Across the Life Course
Sadiya S Khan, Hongyan Ning, Arjun Sinha, et al.
Page
of 161
Search research articles
Search
Showing results (961-970 of 1,607) with videos related to
Sort By:
Page
of 161
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
April 13, 2026
Development of a machine learning-based survival prediction model for ALS inclusive of the advanced-stage population
Danielle Beaulieu, Kelly Smith, Campbell Ross, et al.
Journal of Animal Science
|
January 27, 2016
Relationship of glucocorticoids and hematological measures with feed intake, growth, and efficiency of finishing beef cattle
A P Foote, K E Hales, R G Tait, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration
|
December 19, 2017
Experience with telemedicine in a multi-disciplinary ALS clinic
Marc Van De Rijn, Sabrina Paganoni, Mark Levine-Weinberg, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 9, 2022
Correction to: Identification of Fall-Related Injuries in Nursing Home Residents Using Administrative Claims Data
Joel Mintz, Matthew S Duprey, Andrew R Zullo, et al.
Diabetes & Vascular Disease Research
|
July 17, 2014
Is cardiorespiratory fitness a determinant of cardiomyopathy in the setting of type 2 diabetes?
Martin Sénéchal, Colby R Ayers, Lidia S Szczepaniak, et al.
Journal of Immunological Methods
|
October 16, 2007
High-throughput homogeneous immunoassay readily identifies monoclonal antibody to serovariant clostridial neurotoxins
Cindi R Corbett, Mohammad D Elias, Lance L Simpson, et al.
Cancer Chemotherapy and Pharmacology
|
October 27, 1998
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer
C J Gilbert, W P Petros, J Vredenburgh, et al.
Diabetes, Obesity & Metabolism
|
April 26, 2014
Dose-finding results in an adaptive, seamless, randomized trial of once-weekly dulaglutide combined with metformin in type 2 diabetes patients (AWARD-5)
Z Skrivanek, B L Gaydos, J Y Chien, et al.
Drug Discovery Today
|
September 11, 2014
Neuroprotective agents target molecular mechanisms of disease in ALS
Yongjin Zhu, Anastasios Fotinos, Lilly L J Mao, et al.
Journal of the American Heart Association
|
November 17, 2021
Cigarette Smoking and Competing Risks for Fatal and Nonfatal Cardiovascular Disease Subtypes Across the Life Course
Sadiya S Khan, Hongyan Ning, Arjun Sinha, et al.
Page
of 161